The Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. […]
Vancouver, British Columbia–(Newsfile Corp. – February 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC PINK: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
PurCann, a subsidiary of SiliCycle, is recognized for its unique expertise in the Extraction-Purification and commercialization of cannabinoids. […]
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions […]
Eastplats issued 36,841,741 common shares of the Company (each a “Common Share”) at a price of CDN$0.32 per Common Share […]
Vancouver, British Columbia–(Newsfile Corp. – January 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
THIS INTERVIEW HAS EXPIRED
Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced […]
During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]
TORONTO – January 19, 2021 − CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com